The andrographolide derivative, AND7, and TRAIL combination attenuates acute lymphoblastic leukemia through P53-regulated ROS accumulation
Acute lymphoblastic leukemia (ALL) is a malignant disease of the hematologic system. The current treatment is based on chemotherapeutic drugs, which are becoming less effective due to drug resistance. TNF-related apoptosis-inducing ligand (TRAIL) is an apoptotic protein used to treat cancer that doe...
Saved in:
Main Authors: | Letian Xu (Author), Yuting Zhou (Author), Rui Ma (Author), Xinqin Guo (Author), Hao Chen (Author), Lei Fan (Author), Xiaoming Wang (Author) |
---|---|
Format: | Book |
Published: |
Compuscript Ltd,
2024-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
dic(7;9) with loss of Tp53 gene in acute lymphoblastic leukemia
by: Anurag Gupta, et al.
Published: (2016) -
Andrographolide inhibits growth of human T-cell acute lymphoblastic leukemia Jurkat cells by downregulation of PI3K/AKT and upregulation of p38 MAPK pathways
by: Yang T, et al.
Published: (2016) -
Andrographolide contributes to the attenuation of cardiac hypertrophy by suppressing endoplasmic reticulum stress
by: Qingxin Tian, et al.
Published: (2023) -
P53-MDM2 PATHWAY: EVIDENCES FOR A NEW TARGETED THERAPEUTIC APPROACH IN B-ACUTE LYMPHOBLASTIC LEUKEMIA
by: Stefania Trino, et al.
Published: (2016) -
Treatment of acute lymphoblastic leukemia with protocol Hongkong-Indonesia Acute Lymphoblastic Leukemia 97
by: Johannes Bondan Lukito
Published: (2007)